Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Trials

Fig. 1

From: Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial

Fig. 1

Schedule of enrolment, interventions, and assessments. EPO erythropoietin, RVP Rapid Visual Information Processing (CANTAB, Cambridge Cognition Ltd.), FAST Functional Assessment Short Test, RAVLT Rey Auditory Verbal Learning Test, RBANS Repeatable Battery for the Assessment of Neuropsychological Status, WAIS-III LNS Wechsler Adult Intelligence Scale Version III Letter-Number Sequencing, OTS One Touch Stockings of Cambridge, SWM Spatial Working Memory, TMT-A Trail Making Test Part A, TMT-B Trail Making Test Part B, AQoL Assessment of Quality of Life, COBRA Cognitive Complaints in Bipolar disorder Rating Assessment, SDS Sheehan Disability Scale, UPSA-B UCSD Performance-Based Skills Assessment-B, WHOQOL-BREF World Health Organization Quality of Life, WSAS Work and Social Adjustment Scale, DART Danish Adult Reading Test, CTQ Childhood Trauma Questionnaire, SCIP Screen for Cognitive Impairment in Psychiatry (Danish version)

Back to article page